In Vivo Services

At Redoxis, we offer a comprehensive portfolio of in vivo models designed to support early drug development within inflammation, autoimmunity, and immunology-driven disease areas. With deep scientific expertise, robust methodologies, and a commitment to high-quality data, our in vivo team provides reliable and translational insights for therapeutic candidates across multiple modalities.
Our services span a wide range of established and custom-developed disease models, including rheumatoid arthritis, multiple sclerosis/EAE, inflammatory bowel disease, psoriasis, GBS, and acute inflammation. Each model is carefully optimized and validated to ensure reproducibility, biological relevance, and clear readouts tailored to customer needs.
Redoxis’ in vivo studies are performed by a team of experienced scientists and technicians with strong backgrounds in immunology, pharmacology, and animal model development. We offer:

• Disease induction and therapeutic intervention studies across acute and chronic models

• Pharmacokinetic and pharmacodynamic evaluations

• Dose–response and mechanism-of-action investigations

• Biomarker profiling using flow cytometry, ELISA, Luminex, and histological analyses

• Customized study design to address specific research questions or novel target mechanisms

With a focus on scientific rigor, animal welfare, and transparent communication, we work closely with our clients to design and execute studies that deliver meaningful, high-quality data.

Our goal is to be a trusted partner in your preclinical development journey—providing the expertise, flexibility, and collaborative mindset needed to move promising therapeutic concepts toward clinical translation.